Research and Development
PCI Pharma Services’ Ian Parsonage to Share Serialization Expertise at Global Track & Trace Conference
April 21, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ian parsonage, pci pharma, serialisation
Shares plunge at Sarepta after negative FDA review on muscle disorder drug
April 21, 2016 Research and Development, Sales and Marketing FDA, Sarepta Therapeutics, Shares, dive, fall, negative, plunge, sarepta
GW Pharma’s cannabis-based epilepsy drug granted orphan designation by FDA
April 21, 2016 Research and Development, Sales and Marketing GW Pharma, cannabis, cannabis-based, epilepsy
Novartis drug Afinitor significantly reduces seizures in TSC patients
April 21, 2016 Research and Development Afinitor, Novartis, Tuberous Sclerosis Complex, drug, seizure, seizures, tsc
BioMarin announces positive data from early stage trials of haemophilia A gene therapy
April 21, 2016 Research and Development BioMarin Pharmaceutical, Phase II, drug trial, haemophilia A gene therapy
Amgen’s drug reduces rates of bleeding in rare childhood disorder
April 21, 2016 Research and Development, Sales and Marketing Amgen, blood disorder, children, nplate, paediatric, platelet, rare, romisplostim
Abbvie acquires immune-oncology target from argenx
April 21, 2016 Research and Development, Sales and Marketing AbbVie, Protein, argenx, garp, immuno-oncology, immunosuppresive
Illumina shares plunge as it cuts Q1 outlook
April 20, 2016 Research and Development, Sales and Marketing Financial, Illumina, Share price, Shares, outlook, revenue, stock market
Focus: Bristol-Myers Squibb’s wonder drug – Opdivo
April 20, 2016 Research and Development, Sales and Marketing BMS, growth, immuno-oncology, opdivo, sales
Lilly and Boehringer Ingelheim to evaluate diabetes drug for treatment of heart failure
April 20, 2016 Research and Development Boehringer Ingelheim, Eli Lilly, cardiovascular death, diabetes, heart attack, jardiance, lilly
Boehringer Ingelheim posts 11% rise in FY15 sales boosted by diabetes business
April 20, 2016 Business Services, Research and Development, Sales and Marketing Boehringer Ingelheim, FY, earnings, forecasts, outlook, results
Gilead presents data highlighting progress and efficacy in liver and hepatitis C therapies
April 20, 2016 Research and Development, Sales and Marketing Gilead, harvoni, hepatitis, liver, sofosbuvir
J&J raises FY outlook, Q1 beats estimates
April 20, 2016 Business Services, Research and Development, Sales and Marketing Financial, Johnson & Johnson, Q1, earnings, results, revenue, sales
Lemtrada shows clinical efficacy in multiple sclerosis in 10-year follow-up data
April 20, 2016 Research and Development, Sales and Marketing Lemtrada, Sanofi, alemtuzumab, multiple sclerosis, sanofi genzyme
Bayer says its Xarelto shows lower risk of stroke, brain haemorrhage for irregular heart rhythm condition vs BMS’ Coumadin
April 19, 2016 Manufacturing and Production, Research and Development Bayer, Bristol-Myers Squibb, anti blood-clot, drug trial
